Home
Notification
Profile
Trending Articles
News
Bookmarked and Liked
History
Creator Center
Settings
Hassnainq012
--
Follow
Oh brother, close it quickly or you will get into trouble 😐
Zeniths
--
$XNY Support level breakdown 👁️🗨️👁️🗨️
Big Down Coming soon ♦️♦️
So Don’t miss Short Position open now
$XNY
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.
See T&Cs.
1
0
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Sign Up
Login
Relevant Creator
Hassnainq012
@Square-Creator-0fe4af799819
Follow
Explore More From Creator
$beat short position
--
$ASTER bulls are coming 💪
--
REDSEPTEMBER ALERT: WHAT THE FED RATE CUT MEANS FOR MARKETS 🔥 The potential Fed rate cut on September 18 could shake up global markets. Here’s the breakdown: U.S. Stocks 🚨 • High rates have kept capital flowing into the U.S. • A rate cut could lead to outflows, pushing the economy toward recession. • This could burst the stock market bubble, triggering a reset on Wall Street. A-Shares 🇨🇳 • A Fed rate cut may bring in hot money for China. • But a U.S. market crash could hurt A-shares, especially in overheated sectors like AI and chips. Market Context 📊 • Last year’s surprise rate cut led to major policy shifts. Stay alert—September 18 could bring big changes! #ListedCompaniesAltcoinTreasury #RedSeptember #Write2Earn
--
President Donald Trump is now considering tariffs on pharmaceuticals, a sector that has long been exempt from trade duties. The proposal could mean import taxes as high as 200% on foreign-made drugs, a move Trump says will push companies to manufacture in the U.S. and lower drug costs. Critics argue the opposite: tariffs could disrupt global supply chains, drive out cheaper generics, and raise U.S. drug prices by 10–14% over time. Analysts also warn of potential shortages if generic manufacturers leave the market. While Trump may delay tariffs until 2026 to allow stockpiling and factory investment, even a 25% levy could reshape the pharmaceutical landscape. Supporters say the policy is about national security, reducing dependence on China and other countries, while skeptics highlight the heavy costs and years needed to rebuild U.S. drug production. Follow @Hassnainq012 for more 🤝 #DonaldTrump #Pharmaceuticals #Tariffs #Healthcare #Economy #Hassnainq012
--
Todays Top Breakout Coins on Binance 1. SOPH Price ek dam se +39.93% spike hua, consolidation base (~$0.050) se breakout karke ab $0.07005 tak pohcha. Strong volume spike ne breakout confirm kiya — agar $0.074 tak resistances toot gaye, to agla target $0.08+ ho sakta hai. 2. MUBARAK Price ne $0.0414 ke low se +14.69% upar, parabolic curve ke saath breakout dikhaya. Volume > 380M aur MA60 ke upar hold ne bullish control signal diya. Next level to watch: $0.0491, breakout par $0.052–$0.058 tak jaa sakta hai. 3. HYPER Ek din mein +257.11% rally ke saath market ko surprise kiya, low $0.0900 se high $0.3666 tak reach hua. Massive bullish engulfing candle, ab $0.32+ par consolidate ho raha hai, continuation ka strong chance hai. 4. FUN, KAITO, OG, SYN Ye top gainers hain: FUN: +26.56%, breakout from consolidation KAITO: +20.42%, sustained buying OG: +12.28%, bullish continuation SYN: +10.14%, gains holding strong
--
Latest News
Ripple National Trust Bank Receives Conditional Approval from OCC
--
BitGo Receives Conditional Approval to Become a National Trust Bank
--
Significant SOL Transfer to Fireblocks Custody
--
Significant SOL Transfer from Hyperunit to Wintermute
--
Crypto Investor Faces Significant Losses Amid Liquidation
--
View More
Trending Articles
💰 Shiba Inu goes bullish · High probability chart setup
GK-ARONNO
🚨🔴🔴A Big Warning for Everyone in Crypto
TechnicalTrader
BREAKING: DO KWON SENTENCED TO 15 YEARS IN U.S. FEDERAL PRIS
CryptoPatel
$ETH With the little pump on lower timeframe, the liquidit
CryptoCap1ain
🚀 Could $DOT hit its all-time high again? Polkadot’s peak w
President_Trump
View More
Sitemap
Cookie Preferences
Platform T&Cs